ArticleAnnals of neurosciences2026
Guillain-Barré Syndrome Following Dengue Infection: A Case Series with Review of Literature.
Article in Annals of neurosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Before Dengue Is Implicated as the Cause of Polyradiculitis, the Infection Must Be Confirmed by Nucleic Acid Amplification Testing or Cell Cultures.Annals of neurosciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Guillain-Barré syndrome (GBS) is a rare, immune-mediated disorder of the peripheral nerve and roots often triggered by infections. Purpose: We report clinical profile, electrophysiological variants and response to treatment in five cases of GBS patients following dengue fever. Methods: Patients fulfilling the National Institute of Neurological and Communicative Disorders and Stroke criteria for GBS following dengue infections were consecutively enrolled. Their demographic, biochemical and nerve conduction study (NCS) was done. According to NCS, they were categorised into acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy, acute motor sensory axonal neuropathy (AMSAN), inexcitable motor nerve and equivocal. Disability was assessed using the 0-6 Guillain-Barré Syndrome Disability Scale or Hughes Functional Grading Scale. Results: Five patients of GBS following dengue fever were recruited (3 male and 2 female) with ages between 24 and 55 years. Diagnosis of dengue was based on serological evidence showing IgM and nonstructural protein 1 positivity. All the patients presented with an acute onset of progressive symmetrical flaccid paralysis. NCS showed a demyelinating pattern in four patients and an AMSAN pattern in one patient. All the patients were treated with intravenous immunoglobulin (IVIG) @2 g/kg/body weight given over 5 days. Modified Hughes grade at presentation was 4 in four patients, and one patient had a modified Hughes grade 5. At 1 month of follow-up, the patient with the AIDP variant showed good recovery and was able to ambulate unaided. Conclusion: GBS following dengue infection usually presents within 2 weeks of infection. In these patients, AIDP variant GBS are more common, and they show good response to IVIG treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.